BioLase Technology Inc (BIOL): The run from Jan 1st was substantial and...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

BioLase Technology Inc (BIOL)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	789
Boards Moderated	0
Alias Born	01/10/2010

Re: John B post# 482

Thursday, 06/13/2013 4:04:49 PM

Thursday, June 13, 2013 4:04:49 PM

The run from Jan 1st was substantial and is the reason I decided to sell all of my shares @ $5.75, I just felt that a pullback was coming. Since I've owned this stock at minimum 10 sharp pullbacks have occurred. To say I thought it would pull back to $3.75 would be a stretch. I am not worried in the least bit about anything shady going on and I feel your thoughts about being due for a correction, market weakness and the low float are the culprits here. I am currently averaged in @ $4.65 per share and now own 30% more shares of BIOL than I did when I sold @ $5.75

Maybe we finally found support @ $3.75

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BIOL News

Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:05:18 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 11:31:05 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:05:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:14:14 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:05:29 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:39:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:01:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:15:33 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:10:34 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:26 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:03:55 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 01:44:40 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 11:11:07 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 11:04:56 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/31/2024 02:57:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 10:01:33 PM
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024 • PR Newswire (US) • 01/29/2024 11:30:00 AM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/24/2024 10:21:31 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 11:09:03 AM
BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023 • PR Newswire (US) • 01/08/2024 09:05:00 PM
BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD • PR Newswire (US) • 01/03/2024 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:28 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/26/2023 10:22:25 PM
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD • PR Newswire (US) • 12/14/2023 09:05:00 PM

More BIOL News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow